NOVOZYMES A/S SPONS.ADR 1 Cash Flow Reinvestment Rate
NOVOZYMES A/S SPONS.ADR 1 cash flow reinvestment rate. NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Cash Flow Reinvestment Rate of 0.56x as of March 2026, reinvesting €93.10 Million (capex €93.10 Million ) from operating cash flow of €167.10 Million. See NZM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
Cash flow reinvestment rate of NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025. Historical reinvestment intensity for NOVOZYMES A/S SPONS.ADR 1 across 5 annual periods. Explore NOVOZYMES A/S SPONS.ADR 1 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
NOVOZYMES A/S SPONS.ADR 1 Cash Flow Reinvestment Rate by Year (2021–2025)
NOVOZYMES A/S SPONS.ADR 1 cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for NOVOZYMES A/S SPONS.ADR 1. For the full cash flow conversion analysis, see cash flow conversion of NOVOZYMES A/S SPONS.ADR 1.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | €470.80 Million | €1.22 Billion | €470.80 Million | ▲ +9.3% |
| 2024 | 0.35x | €359.80 Million | €1.02 Billion | €359.80 Million | ▼ -28.7% |
| 2023 | 0.50x | €275.80 Million | €557.10 Million | €275.80 Million | ▼ -31.4% |
| 2022 | 0.72x | €387.87 Million | €537.65 Million | €387.87 Million | ▲ +136.3% |
| 2021 | 0.31x | €166.73 Million | €546.17 Million | €166.73 Million | — |